Company intelligence / Profile preview
Premium Serums and Vaccines
- Ownership
- Private
- Development stage
- Other
Overview
Premium Serums and Vaccines manufactures and exports equine immunoglobulin-based antivenoms and antitoxins, including products recommended by the WHO for the treatment of snake envenoming in India and sub-Saharan Africa. Their products are supplied globally and included in UN agency procurement programs. Published independent evaluations indicate their snake antivenoms show intermediate binding strength against major Indian snake venoms in vitro compared to other suppliers[6].
- Therapeutic areas
- OtherInfectious Diseases
- Modalities
- AntibodyBiologicVaccine
- Industry
- Biotech
Drug pipeline
5 assets4 more assets in the full pipeline.
Request access →Partnerships
Beyond the preview
Go deeper on Premium Serums and Vaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Premium Serums and Vaccines.